Merck & Co Inc

Despite calls from some analysts to reconsider tech stocks, Deuterium Capital's John Ricciardi says it's not yet time to buy the dip. The tech sector has sold off massively this year as investors rotated into value from growth names, on…

A trader works on the floor of the New York Stock Exchange (NYSE), June 27, 2022.Brendan McDermid | ReutersThere's a head-spinning amount of news for markets to navigate in the week ahead, the biggest of which will be the Federal…

The pace of biotech deals is likely to pick up, but investors should think about smaller targets, said Wells Fargo analyst Mohit Bansal. Bansal called out both enticing valuations for small- and mid-cap biotech companies, which are now…